Hedge Fund and Insider Trading News: Bill Miller, Seth Klarman, Ken Griffin, Jim Simons, Blue Ridge Capital, Phillips 66 Partners LP (PSXP), PNC Financial Services Group Inc (PNC), and More

A Director at PNC Financial (NYSE: PNC) is Buying Shares (Analyst Ratings)
Today, a Director at PNC Financial (PNC), Charles Bunch, bought shares of PNC for $153.1K. Following Charles Bunch’s last PNC Buy transaction on August 27, 2019, the stock climbed by 29.4%. Following this transaction Charles Bunch’s holding in the company was increased by 26.45% to a total of $725K.

Thursday 1/23 Insider Buying Report: PSXP, HARP (Market Watch)
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let’s look at two noteworthy recent insider buys. At Phillips 66 Partners, a filing with the SEC revealed that on Wednesday, Director Mark Haney purchased 1,640 shares of PSXP, for a cost of $62.17 each, for a total investment of $101,967. Bargain hunters are able to snag PSXP at a price even lower than Haney did, with the stock trading as low as $60.50 in trading on Thursday — that’s 2.7% under Haney’s purchase price. Phillips 66 Partners is trading up about 0.1% on the day Thursday. This purchase marks the first one filed by Haney in the past twelve months.

The EVP, Chief Accounting Officer of Simmons 1st Nat’l (NASDAQ: SFNC) is Buying Shares (Analyst Ratings)
Yesterday, the EVP, Chief Accounting Officer of Simmons 1st Nat’l (SFNC), David Garner, bought shares of SFNC for $13.46K. In addition to David Garner, 19 other SFNC executives reported Buy trades in the last month. Following this transaction David Garner’s holding in the company was increased by 1.09% to a total of $1.25 million.

Harpoon Therapeutics Inc (HARP) CFO Georgia Erbez Bought $94,403 of Shares (Guru Focus)
CFO of Harpoon Therapeutics Inc., Georgia Erbez, bought 6,700 shares of HARP on 01/21/2020 at an average price of $14.09 a share. The total cost of this purchase was $94,403. Harpoon Therapeutics Inc has a market cap of $340.257 million; its shares were traded at around $13.81 with and P/S ratio of 63.35. GuruFocus has detected 1 severe warning sign with Harpoon Therapeutics Inc.